Health ❯ Diabetes ❯ Type 2 Diabetes

Treatment Options

GLP-1 Agonists GLP-1 Receptor Agonists Clinical Trials GLP-1 Medications Semaglutide Mounjaro vs Ozempic Mounjaro GLP-1 Drugs Oral Medications Medications Ozempic Orforglipron Wegovy Novo Nordisk Elenolic Acid Tirzepatida Weight Loss Injections Weight Loss Medications Injectable vs Oral Medications Medication Effects Medication Semaglutide Injection Injectable Medications CagriSema GLP-1 Therapy Tirzepatide Weight Management Insulin Glargine Rybelsus

Wegovy Pill Debuts to Strong U.S. Demand as Next‑Gen Obesity Drugs Near Decisions

Early prescription data show strong uptake driven by a needle‑free option with efficacy comparable to injections.

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials